OPKO Health, Inc. (OPK)
1.18
+0.01
(+0.85%)
USD |
NASDAQ |
Apr 15, 16:00
1.17
-0.01
(-0.85%)
After-Hours: 06:18
OPKO Health Research and Development Expense (Annual) : 124.03M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Align Technology, Inc. | 369.91M |
| AtriCure, Inc. | 90.17M |
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| OrthoPediatrics Corp. | 9.102M |